Mercado de dispositivos de teste de cuspo de cancro da América do Norte – Tendências do setor e previsão para 2028

Análise de mercado e insights: Mercado de dispositivos de teste de cuspo de cancro na América do Norte

Espera-se que o mercado norte-americano de dispositivos de teste de cuspo de cancro ganhe um crescimento significativo no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado norte-americano de dispositivos de teste de cuspo de cancro do Norte está a crescer com um CAGR de 10,0% no período de previsão de 2021. até 2028 e deverá atingir os 473,28 milhões de dólares até 2028, contra 230,06 milhões de dólares em 2020. O aumento da prevalência de doenças crónicas e o aumento de doentes oncológicos são os principais impulsionadores, que deverão impulsionar o crescimento do mercado no período de previsão.

Um teste de saliva é amplamente utilizado para a deteção de cancro. A saliva do cancro testaria a presença ou ausência de ADN e ARN extracelular mutados. As células tumorais libertam ADN e ARN na circulação e chegam à saliva, sendo que as mutações são detetáveis ​​com grande precisão na saliva.

O mercado de dispositivos de teste de saliva para o cancro é composto por kits de teste, cotonetes, cassetes e dispositivos utilizados para a deteção de drogas , infeções ou doenças em seres humanos. Vários tipos de kits utilizam diferentes tipos de métodos de biologia molecular para a deteção de doenças. O ELISA, o PCR, o imunoensaio e os ensaios enzimáticos, entre outros, são técnicas moleculares utilizadas para testes de saliva.

O relatório de mercado de dispositivos de teste de cuspo de cancro da América do Norte fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa as oportunidades em termos de bolsas de receitas emergentes , alterações nas regulamentações de mercado, aprovações de produtos, decisões estratégicas , lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um Analyst Brief, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.   

Âmbito do mercado e tamanho do mercado de dispositivos de teste de cuspo de cancro na América do Norte

North America cancer spit test device market is segmented on the basis of product type, site of collection, application, age group, method of collection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of product type, the North America cancer spit test devices market is segmented into saliva collection kits, fluid specific devices, oral swab, bar-code labels, saliva cryostorage box, and others. In 2021, saliva collection kits segment is expected to dominate the market due to increasing demand for POCT devices and rising prevalence of cancer patients in the region. .
• On the basis of site of collection, the North America cancer spit test devices market is segmented into sub-mandibular/sub-lingual gland, parotid gland, and minor salivary gland. In 2021, sub-mandibular/sub-lingual gland segment is expected to dominate the market owing to surging pool of cancer patients and increasing healthcare expenditure.
• On the basis of application, the North America cancer spit test devices market is segmented into liver-lung cancer, breast cancer, colon and rectal cancer, prostate cancer, pancreatic cancer, oral cancer, thyroid cancer, endometrial cancer, kidney cancer, leukemia, melanoma, non-hodgkin lymphoma, and others. In 2021, liver-lung cancer segment is expected to dominate the market because of changing lifestyle and rising incidences of liver cirrhosis.
• On the basis of age group, the North America cancer spit test devices market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market because of increasing geriatric population and rising prevalence of chronic diseases in the region.
• On the basis of method of collection, the North America cancer spit test devices market is segmented into passive drool, oral swab, and others. In 2021, passive drool segment is expected to dominate the market because it is stored and collected with better patient compliance.
• On the basis of end user, the North America cancer spit test devices market is segmented into hospitals, diagnostic laboratories, oncology specialty clinics, cancer research institutes, and others. In 2021, hospitals segment is expected to dominate the market because of growing awareness among people about cancer and its treatment.
• On the basis of distribution channel, the North America cancer spit test devices market is segmented into direct tender, retail sales, and others. In 2021, direct sales segment is expected to dominate the market owing to rising healthcare expenditure and easy accessibility of products.

North America Cancer Spit Test Devices Market Country Level Analysis

The North America cancer spit test devices market is analyzed and market size information is provided based on product type, site of collection, application, age group, method of collection, end user, and distribution channel.

Countries covered in the North America cancer spit test device market report are the U.S., Canada, and Mexico. North America is expected to dominate the cancer spit test devices market due to rising prevalence of chronic diseases in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Rising Healthcare Expenditure and High Prevalence of Cancer are Creating New Opportunities for Players in the North America Cancer Spit Test Devices Market

Saliva collection kits segment in the U.S. is expected to grow with the highest rate and is dominating North America region in the forecast period of 2021 to 2028 owing to rising prevalence of cancer in the country.

North America cancer spit test devices market also provides you with detailed market analysis for every country growth in particular industry with the North America cancer spit test device market sales, impact of advancement in the North America cancer spit test device market and changes in regulatory scenarios with their support for the North America cancer spit test devices market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and North America Cancer Spit Test Device Market Share Analysis

North America cancer spit test device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus related to North America cancer spit test devices market.

Os principais players abordados no relatório são a DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. KG, Miraclean Technology Co., Ltd., Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Oasis Diagnostics Corporation, Canvax (uma subsidiária da dobuss), entre outros players nacionais e da América do Norte. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

Muitos lançamentos de produtos e acordos são também iniciados pelas empresas de todo o mundo, que estão a acelerar ainda mais o crescimento do mercado de dispositivos de teste de cuspo de cancro na América do Norte.

Por exemplo,

• Em janeiro de 2021, a DNA Genotek anunciou que a Food and Drug Administration (FDA) dos EUA concedeu uma autorização 510(k) de utilização geral para a sua família de produtos OrageneDx. Esta aprovação da FDA aumentou a credibilidade da empresa no mercado e aumentou a procura deste produto.
• Em fevereiro de 2021, a Thermo Fisher Scientific foi reconhecida com seis CMO Leadership Awards. Venceu em todas as seis categorias, incluindo capacidades, compatibilidade, experiência, qualidade, fiabilidade e serviço. Este é o segundo ano consecutivo em que a Thermo Fisher recebe este reconhecimento em todas as seis categorias e a oitava vez no geral que a empresa é homenageada pelos CMO Leadership Awards. Isto aumentou a credibilidade da empresa e ajudou na geração de receitas.

SKU-64146